VBI Vaccines Inc.

VBI Vaccines Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.93
Market Cap
$93.06 M
Shares Outstanding
97.66 M
Public Float
78.16 M

Profile

Address
222 3rd Street
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.vbivaccines.com
Updated 07/08/2019
VBI Vaccines, Inc. is a biopharmaceutical company, which develops vaccines for infectious disease and immuno-oncology. Its pipeline includes Sci-B-Vac, CMV Vaccine, GBM Immunotherapy, MB Immunotherapy, and Zika Vaccine. The company was founded on July 9, 2015 is headquartered in Cambridge, MA.

Financials

View All
Created with Highcharts 5.0.14VBI Vaccines Inc.Net Income. Fiscal year is January-December. All values USD Thousands.6 7606 7604 8214 82126 19326 19323 20523 20538 99538 99563 60063 600201320142015201620172018020k40k60k80k
Created with Highcharts 5.0.14VBI Vaccines Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.00009559555485488658653 3553 35520132014201520162017201801k2k3k4k

Jeffrey Baxter
President, Chief Executive Officer & Director
Tomer Kariv
Director